{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T20:49:36Z","timestamp":1793566176004,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00125-019-05034-1","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:09:05Z","timestamp":1575504545000},"page":"229-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group"],"prefix":"10.1007","volume":"63","author":[{"given":"G. Alexander","family":"Fleming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Bergenstal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard W.","family":"Holl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,5]]},"reference":[{"issue":"10027","key":"5034_CR1","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","volume":"387","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2016","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2016) Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387(10027):1513\u20131530","journal-title":"Lancet"},{"issue":"7588","key":"5034_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/bmj.39063.689375.55","volume":"334","author":"CL Gillies","year":"2007","unstructured":"Gillies CL, Abrams KR, Lambert PC et al (2007) Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. Br Med J 334(7588):299. https:\/\/doi.org\/10.1136\/bmj.39063.689375.55","journal-title":"Br Med J"},{"issue":"6","key":"5034_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393\u2013403. https:\/\/doi.org\/10.1056\/NEJMoa012512","journal-title":"N Engl J Med"},{"issue":"18","key":"5034_CR4","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","volume":"344","author":"J Tuomilehto","year":"2001","unstructured":"Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344(18):1343\u20131350. https:\/\/doi.org\/10.1056\/NEJM200105033441801","journal-title":"N Engl J Med"},{"issue":"1","key":"5034_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1687-9856-2012-28","volume":"2012","author":"N Ramchandani","year":"2012","unstructured":"Ramchandani N, Heptulla RA (2012) New technologies for diabetes: a review of the present and the future. Int J Pediatr Endocrinol 2012(1):28","journal-title":"Int J Pediatr Endocrinol"},{"issue":"Suppl 1","key":"5034_CR6","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1089\/dia.2016.2506","volume":"18","author":"N Kaufman","year":"2016","unstructured":"Kaufman N, Khurana I (2016) Using digital health technology to prevent and treat diabetes. Diabetes Technol Ther 18(Suppl 1):S56\u2013S68","journal-title":"Diabetes Technol Ther"},{"key":"5034_CR7","unstructured":"WHO (2011) mHealth: new horizons for health through mobile technologies. Based on the findings of the second global survey on eHealth. Global Observatory for eHealth series \u2013 Volume 3. WHO, Geneva. Available from www.who.int\/goe\/publications\/goe_mhealth_web.pdf. Accessed 17 Sep 2018"},{"issue":"7","key":"5034_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nbt.3284","volume":"33","author":"E Elenko","year":"2015","unstructured":"Elenko E, Speier A, Zohar D (2015) A regulatory framework emerges for digital medicine. Nat Biotechnol 33(7):697\u2013702. https:\/\/doi.org\/10.1038\/nbt.3284","journal-title":"Nat Biotechnol"},{"key":"5034_CR9","unstructured":"Statista. Number of mHealth apps available in the Apple App Store from 2nd quarter 2015 to 3rd quarter 2018. Available from www.statista.com\/statistics\/779910\/health-apps-available-ios-worldwide\/. Accessed 3 Dec 2018"},{"key":"5034_CR10","unstructured":"Pohl M (2017) 325,000 mobile health apps available in 2017 \u2013 Android now the leading mHealth platform. Available from https:\/\/research2guidance.com\/325000-mobile-health-apps-available-in-2017\/. Accessed 3 Dec 2018"},{"issue":"6","key":"5034_CR11","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.2196\/jmir.2600","volume":"15","author":"B Mart\u00ednez-P\u00e9rez","year":"2013","unstructured":"Mart\u00ednez-P\u00e9rez B, de la Torre-D\u00edez I, L\u00f3pez-Coronado M (2013) Mobile health applications for the most prevalent conditions by the World Health Organization: review and analysis. J Med Internet Res 15(6):e120. https:\/\/doi.org\/10.2196\/jmir.2600","journal-title":"J Med Internet Res"},{"key":"5034_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1177\/0145721708316625","volume":"34","author":"American Association of Diabetes Educators","year":"2008","unstructured":"American Association of Diabetes Educators (2008) AADE7 self-care behaviours. Diabetes Educ 34:445\u2013449","journal-title":"Diabetes Educ"},{"key":"5034_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fendo.2019.00135","volume":"10","author":"MM Kebede","year":"2019","unstructured":"Kebede MM, Pischke CR (2019) Popular diabetes apps and the impact of diabetes app use on self-care behaviour: a survey among the digital community of persons with diabetes on social media. Front Endocrinol (Lausanne) 10:135. https:\/\/doi.org\/10.3389\/fendo.2019.00135","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"5034_CR14","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2337\/dc07-2137","volume":"31","author":"RM Bergenstal","year":"2008","unstructured":"Bergenstal RM, Johnson M, Powers MA et al (2008) Adjust to target in type 2 diabetes. Diabetes Care 31(7):1305\u20131310. https:\/\/doi.org\/10.2337\/dc07-2137","journal-title":"Diabetes Care"},{"issue":"6","key":"5034_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.amepre.2014.01.010","volume":"46","author":"DE Conroy","year":"2014","unstructured":"Conroy DE, Yang CH, Maher JP (2014) Behavior change techniques in top-ranked mobile apps for physical activity. Am J Prev Med 46(6):649\u2013652. https:\/\/doi.org\/10.1016\/j.amepre.2014.01.010","journal-title":"Am J Prev Med"},{"key":"5034_CR16","unstructured":"WellDoc (2017) WellDoc Receives FDA 510(k) Clearance to Offer a Non-Prescription Version of BlueStar\u00ae Digital Therapeutic for Type 2 Diabetes. Available from www.welldoc.com\/news\/welldoc-receives-fda-510k-clearance-to-offer-a-non-prescription-version-of-bluestar-digital-therapeutic-for-type-2-diabetes\/. Accessed 6 Sep 2019"},{"key":"5034_CR17","unstructured":"Brown A. Can diabetes apps make our lives easier? Lecture presented at: ADA Scientific Sessions; 23 June 2018; Orlando, FL. Available from https:\/\/diatribe.org\/Apps2018. Accessed 3 Oct 2019"},{"key":"5034_CR18","unstructured":"Cision PR Newswire (2019) Hygieia receives 510(k) clearance from FDA for phone app that enhances company\u2019s d-Nav insulin guidance service. Available from www.prnewswire.com\/news-releases\/hygieia-receives-510k-clearance-from-fda-for-phone-app-that-enhances-companys-d-nav-insulin-guidance-service-300797091.html. Accessed 26 February 2019"},{"key":"5034_CR19","unstructured":"Schwartz N. FDA perspective: mobile medical apps in diabetes management. Lecture presented at: Diabetes Technology Meeting; 9 Nov 2018; Bethesda, MD"},{"key":"5034_CR20","unstructured":"Companion Medical. InPen. Available from www.companionmedical.com\/InPen\/. Accessed 7 Dec 2018"},{"key":"5034_CR21","unstructured":"Dexcom. Dexcom Clarity. Available from https:\/\/clarity.dexcom.com. Accessed 13 Feb 2019"},{"key":"5034_CR22","unstructured":"Medtronic. Sugar.IQ\u2122 Diabetes Assistant | Exclusive to Guardian\u2122 Connect CGM. Available from www.medtronicdiabetes.com\/products\/sugar.iq-diabetes-assistant. Accessed 13 Feb 2019"},{"key":"5034_CR23","unstructured":"US Food & Drug Administration. What is the pancreas? What is an artificial pancreas device system? Available from www.fda.gov\/medical-devices\/artificial-pancreas-device-system\/what-pancreas-what-artificial-pancreas-device-system. Accessed 12 Jun 2019"},{"key":"5034_CR24","unstructured":"diaTribe. The FDA Approves Medtronic\u2019s MiniMed 670G Hybrid Closed Loop System. Available from https:\/\/diatribe.org\/fda-approval-medtronic-minimed-670g-hybrid-closed-loop-system. Accessed 3 Oct 2019"},{"key":"5034_CR25","unstructured":"Bankmycell.com. How many phones are there in the world? 1 billion more mobile connections than people worldwide. Available from www.bankmycell.com\/blog\/how-many-phones-are-in-the-world#targetText=AccordingtoStatista,thereis,populationhaveasmartphonetoday. Accessed 6 Sep 2019"},{"issue":"6","key":"5034_CR26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s10865-016-9765-3","volume":"39","author":"M Hood","year":"2016","unstructured":"Hood M, Wilson R, Corsica J, Bradley L, Chirinos D, Vivo A (2016) What do we know about mobile applications for diabetes self-management? A review of reviews. J Behav Med 39(6):981\u2013994. https:\/\/doi.org\/10.1007\/s10865-016-9765-3","journal-title":"J Behav Med"},{"issue":"3","key":"5034_CR27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/1932296815576956","volume":"9","author":"DH Fr\u00f8island","year":"2015","unstructured":"Fr\u00f8island DH, \u00c5rsand E (2015) Integrating visual dietary documentation in mobile-phone-based self-management application for adolescents with type 1 diabetes. J Diabetes Sci Technol 9(3):541\u2013548. https:\/\/doi.org\/10.1177\/1932296815576956","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"5034_CR28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/amiajnl-2012-001510","volume":"20","author":"GM Turner-McGrievy","year":"2013","unstructured":"Turner-McGrievy GM, Beets MW, Moore JB, Kaczynski AT, Barr-Anderson DJ, Tate DF (2013) Comparison of traditional versus mobile app self-monitoring of physical activity and dietary intake among overweight adults participating in an mHealth weight loss program. J Am Med Inform Assoc 20(3):513\u2013518. https:\/\/doi.org\/10.1136\/amiajnl-2012-001510","journal-title":"J Am Med Inform Assoc"},{"issue":"3","key":"5034_CR29","doi-asserted-by":"publisher","first-page":"R93","DOI":"10.1530\/EJE-14-0441","volume":"172","author":"Z Huang","year":"2015","unstructured":"Huang Z, Tao H, Meng Q, Jing L (2015) Management of endocrine disease. Effects of telecare intervention on glycemic control in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Eur J Endocrinol 172(3):R93\u2013R101. https:\/\/doi.org\/10.1530\/EJE-14-0441","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"5034_CR30","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.2196\/jmir.2968","volume":"16","author":"M Arnhold","year":"2014","unstructured":"Arnhold M, Quade M, Kirch W (2014) Mobile applications for diabetics: a systematic review and expert-based usability evaluation considering the special requirements of diabetes patients age 50 years or older. J Med Internet Res 16(4):e104","journal-title":"J Med Internet Res"},{"issue":"4","key":"5034_CR31","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.ecl.2016.06.001","volume":"45","author":"A Drincic","year":"2016","unstructured":"Drincic A, Prahalad P, Greenwood D, Klonoff DC (2016) Evidence-based mobile medical applications in diabetes. Endocrinol Metab Clin N Am 45(4):943\u2013965. https:\/\/doi.org\/10.1016\/j.ecl.2016.06.001","journal-title":"Endocrinol Metab Clin N Am"},{"key":"5034_CR32","unstructured":"US Food & Drug Administration (2019) Policy for device software fuctions and mobile medical applications. Available from www.fda.gov\/media\/80958\/download. Accessed 8 Nov 2019"},{"issue":"5","key":"5034_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1177\/1932296818771200","volume":"12","author":"D Kerr","year":"2018","unstructured":"Kerr D, Gabbay RA, Klonoff DC (2018) Finding real value from digital diabetes health: is digital health dead or in need of resuscitation? J Diabetes Sci Technol 12(5):911\u2013913. https:\/\/doi.org\/10.1177\/1932296818771200","journal-title":"J Diabetes Sci Technol"},{"issue":"11","key":"5034_CR34","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1001\/jama.2016.8708","volume":"316","author":"Jeffrey Shuren","year":"2016","unstructured":"Schuren J, Califf RM (2016) Need for a national evaluation system for health technology. JAMA 316(11):1153\u20131154","journal-title":"JAMA"},{"issue":"Suppl 27","key":"5034_CR35","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/pedi.12731","volume":"19","author":"JL Sherr","year":"2018","unstructured":"Sherr JL, Tauschmann M, Battelino T et al (2018) ISPAD clinical practice consensus guidelines 2018: diabetes technologies. Pediatr Diabetes 19(Suppl 27):302\u2013325","journal-title":"Pediatr Diabetes"},{"key":"5034_CR36","unstructured":"European Commission. Guidance document medical devices - scope, field of application, definition - qualification and classification of stand alone software - MEDDEV 2.1\/6. Available from http:\/\/ec.europa.eu\/DocsRoom\/documents\/17921\/attachments\/1\/translations. Updated July 2016. Accessed 19 Sep 2018"},{"key":"5034_CR37","unstructured":"European Commission. Transformation of health and care in the digital single market. Available from https:\/\/ec.europa.eu\/digital-single-market\/en\/european-policy-ehealth. Accessed 19 Sep 2018"},{"key":"5034_CR38","unstructured":"European Commission. EU health policy. Available from https:\/\/ec.europa.eu\/health\/policies\/overview_en. Accessed 19 Sep 2018"},{"issue":"9","key":"5034_CR39","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1056\/NEJMhle1113918","volume":"36","author":"DB Kramer","year":"2012","unstructured":"Kramer DB, Xu S, Kesselheim AS (2012) Regulation of medical devices in the United States and European Union. N Engl J Med 36(9):848\u2013855","journal-title":"N Engl J Med"},{"key":"5034_CR40","unstructured":"European Commission (2016) The \u201cBlue Guide\u201d on the implementation of EU products rules 2016. Available from https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:52016XC0726(02)&rid=7. Accessed 22 Sep 2018"},{"issue":"5","key":"5034_CR41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jacbts.2016.06.003","volume":"1","author":"Gail A. Van Norman","year":"2016","unstructured":"Van Norman GA (2016) Drugs and devices: comparison of European and U.S. approval processes. JACC Basic Transl Sci 1(5):399\u2013412. https:\/\/doi.org\/10.1016\/j.jacbts.2016.06.003","journal-title":"JACC: Basic to Translational Science"},{"key":"5034_CR42","unstructured":"European Commission. Medical Devices Regulatory Framework. Available from https:\/\/ec.europa.eu\/growth\/sectors\/medical-devices\/regulatory-framework_en. Accessed 13 Feb 2019"},{"key":"5034_CR43","unstructured":"L\u00e4kemedelsverket Medical Products Agency. Medical information systems \u2013 guidance for qualification and classification of standalone software with a medical purpose. L\u00e4kemedelsverket Medical Products Agency, Uppsala. Available from https:\/\/lakemedelsverket.se\/upload\/eng-mpa-se\/vagledningar_eng\/medical-information-system-guideline.pdf. Accessed 20 Sep 2018"},{"key":"5034_CR44","unstructured":"European Network of Research Ethics Committee. The Act on Medical Devices (Medical Devices Act) (Medizinproduktegesetz \u2013 MPG) (especially \u00a7\u00a719\u201324). Available from www.eurecnet.org\/legislation\/germany.html. Accessed 20 Sep 2018"},{"key":"5034_CR45","unstructured":"US Food & Drug Administration. Mobile medical applications. Available from www.fda.gov\/medical-devices\/digital-health\/mobile-medical-applications. Accessed 6 Sep 2019"},{"key":"5034_CR46","unstructured":"US Food & Drug Administration. 21st Century Cures Act. Available from www.fda.gov\/regulatoryinformation\/lawsenforcedbyfda\/significantamendmentstothefdcact\/21stcenturycuresact\/default.htm. Accessed 19 Sep 2018"},{"key":"5034_CR47","unstructured":"US Food & Drug Administration. Digital health. Available from www.fda.gov\/MedicalDevices\/DigitalHealth\/default.htm. Accessed 19 Sep 2018"},{"key":"5034_CR48","unstructured":"US Food & Drug Administration. National evaluation system for health technology (NEST). Available from www.fda.gov\/aboutfda\/centersoffices\/officeofmedicalproductsandtobacco\/cdrh\/cdrhreports\/ucm301912.htm. Accessed 13 Feb 2019"},{"key":"5034_CR49","unstructured":"Shuren J (2018) Changing times at the FDA. Lecture presented at: Diabetes Technology Meeting, 9 Nov 2018, Bethesda, MD"},{"issue":"3","key":"5034_CR50","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nbt.3495","volume":"34","author":"JC Kvedar","year":"2016","unstructured":"Kvedar JC, Fogel AL, Elenko E, Zohar D (2016) Digital medicine\u2019s march on chronic disease. Nat Biotechnol 34(3):239\u2013246","journal-title":"Nat Biotechnol"},{"key":"5034_CR51","unstructured":"US Food & Drug Administration (2019) Submitting documents using real-world data and real-world evidence to FDA for drugs and biologics: guidance for industry. Available from www.fda.gov\/media\/124795\/download. Accessed 13 Jun 2019"},{"key":"5034_CR52","unstructured":"US Food & Drug Administration. Use of real-world evidence to support regulatory decision-making for medical devices: guidance for industry and food and drug administration staff. Available from www.fda.gov\/media\/99447\/download. Published 31 Aug 2017. Accessed Jun 13, 2019"},{"key":"5034_CR53","unstructured":"Brown A, Carracher A, Kurian M, et al. JPM 2019: January 7\u201310; San Francisco, CA; Day #2 Highlights \u2013 Draft. Available from www.closeconcerns.com\/knowledgebase\/r\/5a490a4b. Updated 8 Jan 2019. Accessed 23 Jan 2019"},{"key":"5034_CR54","unstructured":"US Food and Drug Administration. Digital health software precertification (Pre-Cert) program. Available from www.fda.gov\/MedicalDevices\/DigitalHealth\/DigitalHealthPreCertProgram\/default.htm. Accessed 13 Jun 2019"},{"key":"5034_CR55","unstructured":"International medical device regulators forum. Available from www.imdrf.org. Accessed 20 Sept 2018"},{"key":"5034_CR56","unstructured":"IMDRF SaMD Working Group (2014) Final document: \u201cSoftware as a Medical Device\u201d: possible framework for risk categorization and corresponding considerations. Available from www.imdrf.org\/docs\/imdrf\/final\/technical\/imdrf-tech-140918-samd-framework-risk-categorization-141013.pdf. Accessed 13 Feb 2019"},{"key":"5034_CR57","unstructured":"IMDRF SaMD Working Group (2015) Proposed document: software as a medical device (SaMD): application of quality management system. Available from www.imdrf.org\/docs\/imdrf\/final\/technical\/imdrf-tech-151002-samd-qms.pdf. Accessed 3 Oct 2019"},{"key":"5034_CR58","unstructured":"International Medical Device Regulators Forum (2017) Software as a medical device (SAMD): clinical evaluation. Guidance for Industry and Food and Drug Administration Staff. Available from https:\/\/www.fda.gov\/media\/100714\/download. Accessed 3 Oct 2019"},{"key":"5034_CR59","unstructured":"World Health Organization (2018) Classification of digital health interventions v1.0: A shared language to describe the uses of digital technology for health. Available from https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/260480\/WHO-RHR-18.06-eng.pdf;jsessionid=CE0199154B170C471D487632C549A142?sequence=1. Accessed 20 Sep 2018"},{"key":"5034_CR60","unstructured":"National Health Service. \u201cHow we access apps\u201d. Available from https:\/\/apps.beta.nhs.uk\/how-we-assess-apps\/. Accessed 24 Jan 2019"},{"key":"5034_CR61","unstructured":"National Health Service. Diabetes-related apps. Available from https:\/\/apps.beta.nhs.uk\/category\/diabetes\/. Accessed 24 Jan 2019"},{"issue":"11","key":"5034_CR62","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.2196\/jmir.5692","volume":"18","author":"J Zhao","year":"2016","unstructured":"Zhao J, Freeman B, Li M (2016) Can mobile phone apps influence people\u2019s health behavior change? An evidence review. J Med Internet Res 18(11):e287. https:\/\/doi.org\/10.2196\/jmir.5692","journal-title":"J Med Internet Res"},{"key":"5034_CR63","unstructured":"Veazie S, Winchell K, Gilbert J, et al (2018) Mobile applications for self-management of diabetes. Technical Brief No. 31. (Prepared by the Scientific Resource Center under Contract Nos. 290- 2012-0004-C and 290-2017-00003-C.) AHRQ Publication No. 18-EHC010-EF. Agency for Healthcare Research and Quality, Rockville"},{"issue":"5","key":"5034_CR64","first-page":"356","volume":"39","author":"CL Ventola","year":"2014","unstructured":"Ventola CL (2014) Mobile devices and apps for health care professionals: uses and benefits. P T 39(5):356\u2013364","journal-title":"P T"},{"issue":"2","key":"5034_CR65","first-page":"48","volume":"3","author":"A Baratloo","year":"2015","unstructured":"Baratloo A, Hosseini M, Negida A, el Ashal G (2015) Part 1: simple definition and calculation of accuracy, sensitivity and specificity. Emerg (Tehran) 3(2):48\u201349","journal-title":"Emerg (Tehran)"},{"issue":"2","key":"5034_CR66","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pec.2012.07.016","volume":"89","author":"NM Hogan","year":"2012","unstructured":"Hogan NM, Kerin MJ (2012) Smart phone apps: smart patients, steer clear. Patient Educ Couns 89(2):360\u2013361. https:\/\/doi.org\/10.1016\/j.pec.2012.07.016","journal-title":"Patient Educ Couns"},{"issue":"10","key":"5034_CR67","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.2337\/dc17-0853","volume":"40","author":"S Chavez","year":"2017","unstructured":"Chavez S, Fedele D, Guo Y, Bernier A, Smith M, Warnick J, Modave F (2017) Mobile apps for the management of diabetes. Diabetes Care 40(10):e145\u2013e146. https:\/\/doi.org\/10.2337\/dc17-0853","journal-title":"Diabetes Care"},{"issue":"2","key":"5034_CR68","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.2196\/jmir.3062","volume":"16","author":"R Bierbrier","year":"2014","unstructured":"Bierbrier R, Lo V, Wu RC (2014) Evaluation of the accuracy of smartphone medical calculation apps. J Med Internet Res 16(2):e32. https:\/\/doi.org\/10.2196\/jmir.3062","journal-title":"J Med Internet Res"},{"issue":"15","key":"5034_CR69","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1001\/jama.2019.1644","volume":"321","author":"Elaine Lum","year":"2019","unstructured":"Lum E, Jimenez G, Huang Z et al (2019) Decision support and alerts of apps for self-management of blood glucose for type 2 diabetes. JAMA 321(15):1530\u20131532. https:\/\/doi.org\/10.1001\/jama.2019.1644","journal-title":"JAMA"},{"key":"5034_CR70","doi-asserted-by":"crossref","unstructured":"Izahar S, Lean QY, Hameed MA et al (2017) Content analysis of mobile health applications on diabetes mellitus. Front Endocrinol (Lausanne) 8:\u2013318","DOI":"10.3389\/fendo.2017.00318"},{"issue":"4","key":"5034_CR71","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2337\/diaspect.26.4.211","volume":"26","author":"RA Ristau","year":"2013","unstructured":"Ristau RA, Yang J, White JR (2013) Evaluation and evolution of diabetes mobile applications: key factors for health care professionals seeking to guide patients. Diabetes Spectrum 26(4):211\u2013215","journal-title":"Diabetes Spectrum"},{"key":"5034_CR72","unstructured":"Apple. Health. Available from www.apple.com\/ios\/health\/. Accessed 3 Oct 2019"},{"key":"5034_CR73","unstructured":"Tidepool. Tidepool Mobile. Available from https:\/\/tidepool.org\/users#mobile. Accessed 13 Feb 2019"},{"key":"5034_CR74","unstructured":"Google. Google Fit. Available from www.google.com\/fit\/. Accessed 13 Feb 2019"},{"key":"5034_CR75","unstructured":"Department of Health and Human Services, Centers for Disease Control and Prevention (2017) National Diabetes Statistics Report, 2017: estimates of diabetes and its burden in the United States. CDC, Atlanta"},{"key":"5034_CR76","unstructured":"Ahn D. Advances in BGM logbooks and apps. Lecture presented at: Diabetes Technology Meeting, 8 Nov 2018, Bethesda, MD"},{"key":"5034_CR77","unstructured":"Rose KJ, K\u00f6nig M, Wiesbauer F. Evaluating success for behavorial change in diabetes via mHealth and gamification: mySugr\u2019s keys to retention and patient engagement. Poster presented at: Advanced Technologies and Treatments for Diabetes; 27 Feb \u2013 3 Mar, 2013; Paris, France. Available from https:\/\/assets.mysugr.com\/website\/mysugr.com-wordpress\/uploads\/2017\/03\/attd-2013-poster.pdf. Accessed 3 Oct 2019"},{"key":"5034_CR78","unstructured":"Medtronic (2018) Medtronic launches patient engagement program that leverages gamification to help motivate and engage patients living with diabetes. Available from http:\/\/newsroom.medtronic.com\/phoenix.zhtml?c=251324&p=irol-newsArticle&ID=2363121. Accessed 24 Jan 2018"},{"key":"5034_CR79","unstructured":"Levine B, Brown A, and Close K (2018) Close Concerns. UnitedHealthcare adds Apple Watch to Motion physical activity incentives program; people with diabetes 40% more likely to enroll in Motion. Available from www.closeconcerns.com\/knowledgebase\/r\/96d89360. Accessed 24 Jan 2019"},{"key":"5034_CR80","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1016\/j.jbi.2017.05.011","volume":"71","author":"L Sardi","year":"2017","unstructured":"Sardi L, Idri A, Fernandez-Aleman JL (2017) A systematic review of gamification in e-Health. J Biomed Inform 71:3148","journal-title":"J Biomed Inform"},{"issue":"10","key":"5034_CR81","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/jama.2015.19426","volume":"315","author":"Sarah R. Blenner","year":"2016","unstructured":"Blenner SR, K\u00f6llmer M, Rouse AJ, Daneshvar N, Williams C, Andrews LB (2016) Privacy policies of android diabetes apps and sharing of health information. JAMA 315(10):1051\u20131052. https:\/\/doi.org\/10.1001\/jama.2015.19426","journal-title":"JAMA"},{"issue":"5","key":"5034_CR82","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1177\/1932296815583334","volume":"9","author":"DC Klonoff","year":"2015","unstructured":"Klonoff DC (2015) Cybersecurity for connected diabetes devices. J Diabetes Sci Technol 9(5):1143\u20131147. https:\/\/doi.org\/10.1177\/1932296815583334","journal-title":"J Diabetes Sci Technol"},{"key":"5034_CR83","unstructured":"Diabetes Technology Society (2017) Standard for wireless diabetes device security (DTSec). Available from www.diabetestechnology.org\/dtsec\/DTSecStandard.pdf. Accessed 16 Nov 2018"},{"key":"5034_CR84","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12916-018-1211-7","volume":"16","author":"JC Wyatt","year":"2018","unstructured":"Wyatt JC (2018) How can clinicians, specialty societies and others evaluate and improve the quality of apps for patient use? BMC Med 16:225","journal-title":"BMC Med"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-05034-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-019-05034-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-05034-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T01:06:57Z","timestamp":1607044017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-019-05034-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,5]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["5034"],"URL":"https:\/\/doi.org\/10.1007\/s00125-019-05034-1","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,5]]},"assertion":[{"value":"5 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No honoraria were received by members of the ADA\u2013EASD Diabetes Technology Committee (AEDTC) for writing this manuscript or associated meetings. Most of the members of the AEDTC work with industry as listed below; however, the industry had no impact on the manuscript and its content.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}},{"value":"GAF is Executive Chairman of Kinexum, which advises multiple health-product companies in the fields of metabolism, cardiovascular, oncology and dermatology. He was formerly the Group Leader of the Division of Metabolism and Endocrine Drug Products at the US Food and Drug Administration (FDA). JRP has served on advisory boards for companies manufacturing pharmaceuticals used in the treatment of diabetes but no digital health companies. RMB has conducted clinical trials, consulted or served on the scientific advisory boards for Abbott Diabetes Care, Becton Dickinson, Bayer, Dexcom, Eli Lilly, Johnson & Johnson, Medtronic, Novo Nordisk, Roche Diabetes Care and Sanofi. He receives no personal income from these activities, for all payment goes to the non-profit Park Nicollet Institute. RWH coordinates the German\/Austrian DPV initiative, which has been supported by Novo Nordisk, Medtronic, Roche, Boehringer-Ingelheim and Eli Lilly through institutional research grants. RWH did not receive any personal honoraria. ALP has served on advisory boards for Abbott Diabetes Care, Eli Lilly, Merck, Novo Nordisk, MannKind, Lexicon, Sanofi and Zafgen. She has received grant funding from AstraZeneca, MannKind and Dexcom. She has been on the Speaker\u2019s Bureau for Novo Nordisk. LH is partner of Profil Institut f\u00fcr Stoffwechselforschung in Neuss, Germany, and of ProSciento in San Diego, CA, USA. He is a member of advisory boards for Roche Diagnostics, Abbott, Zense and Medtronic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}